Protara TherapeuticTARA
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 35 institutions reported holding Protara Therapeutic Inc. (TARA) in their 13F filings, down 3 from Q2 2024. 5 opened new positions and 7 sold out. The largest holders were Ra Capital Management, L.P. ($3.5M), Opaleye Management Inc. ($3.1M) and Stempoint Capital LP ($1.7M). 3 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Protara Therapeutic Inc.
- CUSIP
- 74365U107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $104K |
| Exits | 7 | $1.4M |
All 13F filers, Q2 2024 → Q3 2024: 1,664,717 shares bought and 1,365,841 shares sold, net +298,876 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 35 holders
| Ra Capital Management, L.P. | 0.04% | No change | 1,900,000 | $3.5M |
| Opaleye Management Inc. | 0.52% | Reduce -27.0% | 1,681,154 | $3.1M |
| Stempoint Capital LP | 0.52% | Reduce -4.2% | 942,857 | $1.7M |
| Woodline Partners LP | 0.01% | Add +751.6% | 851,567 | $1.6M |
| Boxer Capital, LLC | 0.07% | No change | 811,627 | $1.5M |
| Vanguard Group Inc. | 0.00% | Add +77.6% | 759,612 | $1.4M |
| Citadel Advisors | 0.00% | Add +2.3% | 680,511 | $1.2M |
| Velan Capital Investment Management LP | 1.14% | Add +19.6% | 574,000 | $1.1M |
| Baker Bros. Advisors LP | 0.01% | No change | 536,832 | $982K |
| Renaissance Technologies | 0.00% | Add +123.9% | 336,740 | $616K |
| Two Sigma Investments, LP | 0.00% | Add +18.9% | 185,223 | $339K |
| Oppenheimer & Co. Inc. | 0.01% | Add +40.8% | 179,125 | $328K |
| Geode Capital Management, LLC | 0.00% | Add +21.0% | 170,040 | $311K |
| Ikarian Capital, LLC | 0.09% | Reduce -13.8% | 155,712 | $285K |
| Two Sigma Advisers, LP | 0.00% | Add +88.3% | 151,618 | $277K |
| BlackRock, Inc. | 0.00% | — | 116,977 | $214K |
| Marshall Wace, LLP | 0.00% | No change | 77,351 | $142K |
| Bridgeway Capital Management, LLC | 0.00% | Add +103.3% | 49,200 | $90K |
| LPL Financial LLC | 0.00% | Add +4.5% | 46,000 | $84K |
| Truist Financial Corp. | 0.00% | Add +100.0% | 40,000 | $73K |
| XTX Topco Ltd | 0.00% | New | 32,682 | $60K |
| Northern Trust Corp. | 0.00% | No change | 28,976 | $53K |
| Cibc World Market Inc. | 0.00% | Reduce -24.3% | 28,000 | $51K |
| State Street Corp. | 0.00% | No change | 26,600 | $49K |
| Commonwealth Equity Services, LLC | 0.00% | No change | 19,428 | $36K |
| Bank of New York Mellon Corp | 0.00% | No change | 17,907 | $33K |
| Boothbay Fund Management, LLC | 0.00% | Reduce -13.8% | 17,398 | $32K |
| Millennium Management | 0.00% | New | 14,402 | $26K |
| UBS Group AG | 0.00% | New | 7,418 | $14K |
| Royal Bank of Canada | 0.00% | Reduce -44.5% | 3,500 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -30.8% | 2,783 | $5K |
| Semmax Financial Advisors Inc. | 0.00% | New | 1,572 | $4K |
| Bank of America Corp. | 0.00% | Add +145.6% | 366 | $670 |
| Osaic Holdings, Inc. | 0.00% | No change | 100 | $183 |
| Simplex Trading, LLC | 0.00% | New | 373 | $0 |
"% of holder's portfolio" is TARA's weight in each manager's 13F, not the share of Protara Therapeutic Inc. the manager owns.